Invasive breast carcinoma - IARC

180. Bapat K, Brustein S (1989). Uterine
sarcoma with liposarcomatous differentiation:
report of a case and review of the literature.
Int J Gynaecol Obstet 28: 71-75.
1 8 1 . Barlund M, Monni O, Kononen J,
Cornelison R, Torhorst J, Sauter G,
Kallioniemi OLLI, Kallioniemi A (2000).
Multiple genes at 17q23 undergo amplification
and overexpression in breast cancer.
Cancer Res 60: 5340-5344.
182. Baron JA (1984). Smoking and estrogen-related
disease. Am J Epidemiol 119:
9-22.
183. Barrett TL, Smith KJ, Hodge JJ, Butler
R, Hall FW, Skelton HG (1997). Immunohistochemical
nuclear staining for p53, PCNA,
and Ki-67 in different histologic variants of
basal cell carcinoma. J Am Acad Dermatol
37: 430-437.
184. Barry TS, Schnitt SJ, Ellis I, Eusebi V,
Gown AM (1999). Absence of myoepithelium
in microglandular adenosis of the
breast confirmed with new myoepithelial
markers. Lab Invest 79: 16A.
1 8 5 . Barter JF, Smith EB, Szpak CA,
Hinshaw W, Clarke-Pearson DL, Creasman
WT (1985). Leiomyosarcoma of the uterus:
clinicopathologic study of 21 cases.
Gynecol Oncol 21: 220-227.
186. Barth RJ Jr. (1999). Histologic features
predict local recurrence after breast conserving
therapy of phyllodes tumors.
Breast Cancer Res Treat 57: 291-295.
186a. Barth A, Craig PH, Silverstein MJ
(1997). Predictors of axillary lymph node
metastases in patients with T1 breast carcinoma.
Cancer 79: 1918-1922.
187. Bartnik J, Powell WS, Moriber-Katz S,
Amenta PS (1989). Metaplastic papillary
tumor of the fallopian tube. Case report,
immunohistochemical features, and
review of the literature. Arch Pathol Lab
Med 113: 545-547.
1 8 8 . Barwick KW, LiVolsi VA (1979).
Heterologous mixed mullerian tumor confined
to an endometrial polyp. O b s t e t
Gynecol 53: 512-514.
189. Barzilai A, Rotman G, Shiloh Y (2002).
ATM deficiency and oxidative stress: a
new dimension of defective response to
DNA damage. DNA Repair (Amst) 1: 3-25.
190. Baschinsky DY, Niemann TH, Eaton
LA, Frankel WL (1999). Malignant mixed
Mullerian tumor with rhabdoid features: a
report of two cases and a review of the literature.
Gynecol Oncol 73: 145-150.
1 9 1 . Bassler R, Katzer B (1992).
Histopathology of myoepithelial (basocellular)
hyperplasias in adenosis and epitheliosis
of the breast demonstrated by the
reactivity of cytokeratins and S100 protein.
An analysis of heterogenic cell proliferations
in 90 cases of benign and malignant
breast diseases. Virchows Arch A Pathol
Anat Histopathol 421: 435-442.
192. Bauer RD, McCoy CP, Roberts DK, Fritz
G (1984). Malignant melanoma metastatic
to the endometrium. Obstet Gynecol 63:
264-268.
193. Bayo S, Bosch FX, de Sanjose S,
Munoz N, Combita AL, Coursaget P, Diaz
M, Dolo A, van den Brule AJ, Meijer CJ
(2002). Risk factors of invasive cervical
cancer in Mali. Int J Epidemiol 31: 202-209.
194. Bebb DG, Yu Z, Chen J, Telatar M,
Gelmon K, Phillips N, Gatti RA, Glickman
BW (1999). Absence of mutations in the
ATM gene in forty-seven cases of sporadic
breast cancer. Br J Cancer 80: 1979-1981.
195. Becker JL, Papenhausen PR, Widen
RH (1997). Cytogenetic, morphologic and
oncogene analysis of a cell line derived
from a heterologous mixed mullerian tumor
of the ovary. In Vitro Cell Dev Biol Anim 33:
325-331.
1 9 6 . Beckmann MW, Niederacher D,
Schnurch HG, Gusterson BA, Bender HG
(1997). Multistep carcinogenesis of breast
cancer and tumour heterogeneity. J Mol
Med 75: 429-439. 197. Beerman H, Smit VT,
Kluin PM, Bonsing BA, Hermans J,
Cornelisse CJ (1991). Flow cytometric
analysis of DNA stemline heterogeneity in
primary and metastatic breast cancer.
Cytometry 12: 147-154.
198. Begin LR, Clement PB, Kirk ME, Jothy
S, McCaughey WT, Ferenczy A (1985).
Aggressive angiomyxoma of pelvic soft
parts: a clinicopathologic study of nine
cases. Hum Pathol 16: 621-628.
1 9 9 . Beilby JO, Parkinson C (1975).
Features of prognostic significance in solid
ovarian teratoma. Cancer 36: 2147-2154.
200. Bell DA (1991). Mucinous adenofibromas
of the ovary. A report of 10 cases. Am
J Surg Pathol 15: 227-232.
201. Bell DA, Scully RE (1985). Atypical and
borderline endometrioid adenofibromas of
the ovary. A report of 27 cases. Am J Surg
Pathol 9: 205-214.
202. Bell DA, Scully RE (1985). Benign and
borderline clear cell adenofibromas of the
ovary. Cancer 56: 2922-2931.
203. Bell DA, Scully RE (1990). Ovarian
serous borderline tumors with stromal
microinvasion: a report of 21 cases. Hum
Pathol 21: 397-403.
204. Bell DA, Scully RE (1990). Serous borderline
tumors of the peritoneum. Am J
Surg Pathol 14: 230-239.
205. Bell DA, Scully RE (1994). Early de
novo ovarian carcinoma. A study of fourteen
cases. Cancer 73: 1859-1864.
206. Bell DA, Shimm DS, Gang DL (1985).
Wilms' tumor of the endocervix. A r c h
Pathol Lab Med 109: 371-373.
207. Bell DA, Weinstock MA, Scully RE
(1988). Peritoneal implants of ovarian
serous borderline tumors. Histologic features
and prognosis. Cancer 62: 2212-2222.
2 0 8 . Bell DA, Woodruff JM, Scully RE
(1984). Ependymoma of the broad ligament.
A report of two cases. Am J Surg Pathol 8:
203-209.
209. Bell DW, Varley JM, Szydlo TE, Kang
DH, Wahrer DC, Shannon KE, Lubratovich
M, Verselis SJ, Isselbacher KJ, Fraumeni
JF, Birch JM, Li FP, Garber JE, Haber DA
(1999). Heterozygous germ line hCHK2
mutations in Li-Fraumeni syndrome.
Science 286: 2528-2531.
210. Bell KA, Smith Sehdev AE, Kurman RJ
(2001). Refined diagnostic criteria for
implants associated with ovarian atypical
proliferative serous tumors (borderline)
and micropapillary serous carcinomas.
Am J Surg Pathol 25: 419-432.
211. Bell SW, Kempson RL, Hendrickson
MR (1994). Problematic uterine smooth
muscle neoplasms. A clinicopathologic
study of 213 cases. Am J Surg Pathol 18:
535-558.
212. Ben David M, Dekel A, Gal R, Dicker D,
Feldberg D, Goldman JA (1988). Prolapsed
cervical leiomyosarcoma. Obstet Gynecol
Surv 43: 642-644.
2 1 3 . Ben David Y, Chetrit A, Hirsh-
Yechezkel G, Friedman E, Beck BD, Beller
U, Ben Baruch G, Fishman A, Levavi H,
Lubin F, Menczer J, Piura B, Struewing JP,
Modan B (2002). Effect of BRCA mutations
on the length of survival in epithelial ovari -
an tumors. J Clin Oncol 20: 463-466.
2 1 4 . Ben Ezra J, Sheibani K (1987).
Antigenic phenotype of the lymphocytic
component of medullary carcinoma of the
breast. Cancer 59: 2037-2041.
2 1 5 . Benatar B, Wright C, Freinkel AL,
Cooper K (1998). Primary extrarenal Wilms'
tumor of the uterus presenting as a cervical
polyp. Int J Gynecol Pathol 17: 277-280.
2 1 6 . Benda JA, Platz CE, Anderson B
(1986). Malignant melanoma of the vulva: a
clinical-pathologic review of 16 cases. Int
J Gynecol Pathol 5: 202-216.
217. Benedet JL, Bender H, Jones H III,
Ngan HY, Pecorelli S (2000). FIGO staging
classifications and clinical practice guidelines
in the management of gynecologic
cancers. FIGO Committee on Gynecologic
Oncology. Int J Gynaecol Obstet 70: 209-
262.
218. Benedet JL, Ehlen TG (2001). Vulvar
Cancer In: Prognostic Factors in Cancer.
MK Gospodarowicz, DE Henson, RV Hutter,
B O'Sullivan, LH Oblin, CH Wittekink (Eds.)
2nd ed. Willey- Liss: New York, pp. 489-500.
2 1 9 . Benedet JL, Miller DM, Ehlen TG,
Bertrand MA (1997). Basal cell carcinoma
of the vulva: clinical features and treatment
results in 28 patients. Obstet Gynecol
90: 765-768.
220. Benedet JL, Murphy KJ, Fairey RN,
Boyes DA (1983). Primary invasive carcinoma
of the vagina. Obstet Gynecol 62: 715-
719.
2 2 1 . Benedetti-Panici P, Maneschi F,
D'Andrea G, Cutillo G, Rabitti C, Congiu M,
Coronetta F, Capelli A (2000). Early cervical
carcinoma: the natural history of lymph
node involvement redefined on the basis of
thorough parametrectomy and giant section
study. Cancer 88: 2267-2274.
2 2 2 . Bennett HGJ, Ehrlich MM (1941).
Myoma of the vagina. Am J Obstet
Gynecol 42: 314-320.
223. Bentz JS, Yassa N, Clayton F (1998).
Pleomorphic lobular carcinoma of the
breast: clinicopathologic features of 12
cases. Mod Pathol 11: 814-822.
224. Beral V (2002). Breast cancer and
breastfeeding: collaborative reanalysis of
individual data from 47 epidemiological
studies in 30 countries, including 50302
women with breast cancer and 96973
women without the disease. Lancet 360:
187-195.
225. Beral V, Banks E, Reeves G, Appleby P
(1999). Use of HRT and the subsequent risk
of cancer. J Epidemiol Biostat 4: 191-210.
226. Beral V, Hermon C, Munoz N, Devesa
SS (1994). Cervical cancer. Cancer surv 19-
20: 265-285.
227. Beral V, Reeves G (1993). Childbearing,
oral contraceptive use, and breast cancer.
Lancet 341: 1102.
228. Berchuck A, Boyd J (1995). Molecular
basis of endometrial cancer. Cancer 76:
2034-2040.
229. Berchuck A, Heron KA, Carney ME,
Lancaster JM, Fraser EG, Vinson VL,
Deffenbaugh AM, Miron A, Marks JR,
Futreal PA, Frank TS (1998). Frequency of
germline and somatic BRCA1 mutations in
ovarian cancer. Clin Cancer Res 4: 2433-
2437.
230. Berchuck A, Kohler MF, Marks JR,
Wiseman R, Boyd J, Bast RC Jr. (1994). The
p53 tumor suppressor gene frequently is
altered in gynecologic cancers. Am J
Obstet Gynecol 170: 246-252.
231. Berchuck A, Rubin SC, Hoskins WJ,
Saigo PE, Pierce VK, Lewis JL Jr. (1988).
Treatment of uterine leiomyosarcoma.
Obstet Gynecol 71: 845-850.
232. Berchuck A, Rubin SC, Hoskins WJ,
Saigo PE, Pierce VK, Lewis JL Jr. (1990).
Treatment of endometrial stromal tumors.
Gynecol Oncol 36: 60-65.
233. Berean K, Tron VA, Churg A, Clement
PB (1986). Mammary fibroadenoma with
multinucleated stromal giant cells. Am J
Surg Pathol 10: 823-827.
234. Berek J, Adashi PA, Hillart PA (1996).
Novak's Gynaecology. XII ed. Williams &
Wilkins: Baltimore, Maryland.
235. Berends MJ, Hollema H, Wu Y, Van
der Sluis T, Mensink RG, ten Hoor KA,
Sijmons RH, de Vries EG, Pras E, Mourits
MJ, Hofstra RM, Buys CH, Kleibeuker JH,
Der Zee AG (2001). MLH1 and MSH2 protein
expression as a pre-screening marker
in hereditary and non-hereditary endometrial
hyperplasia and cancer. Int J Cancer
92: 398-403.
236. Berends MJ, Wu Y, Sijmons RH,
Mensink RG, Van Der Sluis T, Hordijk-Hos
JM, de Vries EG, Hollema H, Karrenbeld A,
Buys CH, van der Zee AG, Hofstra RM,
Kleibeuker JH (2002). Molecular and clinical
characteristics of MSH6 variants: an
analysis of 25 index carriers of a germline
variant. Am J Hum Genet 70: 26-37.
237. Berezowski K, Stastny JF, Kornstein
MJ (1996). Cytokeratins 7 and 20 and carcinoembryonic
antigen in ovarian and
colonic carcinoma. Mod Pathol 9: 426-429.
238. Bergeron C, Ferenczy A, Richart RM,
Guralnick M (1990). Micropapillomatosis
labialis appears unrelated to human papillomavirus.
Obstet Gynecol 76: 281-286.
239. Bergeron C, Ferenczy A, Shah KV,
Naghashfar Z (1987). Multicentric human
papillomavirus infections of the female
genital tract: correlation of viral types with
abnormal mitotic figures, colposcopic
presentation, and location. Obstet Gynecol
69: 736-742.
240. Bergeron C, Nogales FF, Masseroli M,
Abeler V, Duvillard P, Muller-Holzner E,
Pickartz H, Wells M (1999). A multicentric
European study testing the reproducibility
of the WHO classification of endometrial
hyperplasia with a proposal of a simplified
working classification for biopsy and
curettage specimens. Am J Surg Pathol 23:
1102-1108.
241. Bergh J, Norberg T, Sjogren S,
Lindgren A, Holmberg L (1995). Complete
sequencing of the p53 gene provides prognostic
information in breast cancer
patients, particularly in relation to adjuvant
systemic therapy and radiotherapy. Nat
Med 1: 1029-1034.
241a. Bergstrom A, Pisani P, Tenet V, Wolk
A, Adami HO (2001). Overweight as an
avoidable cause of cancer in Europe. Int J
Cancer 91: 421-430.
242. Berkey CS, Frazier AL, Gardner JD,
Colditz GA (1999). Adolescence and breast
carcinoma risk. Cancer 85: 2400-2409.
243. Berkowitz RS, Bernstein MR, Laborde
O, Goldstein DP (1994). Subsequent pregnancy
experience in patients with gestational
trophoblastic disease. New England
Trophoblastic Disease Center, 1965-1992.
J Reprod Med 39: 228-232.
References 375